Project Grant R15GM155805

Award Date 7/2/24
Completion Date 6/30/27
Dollars Obligated $420K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Waco, TX 76798, USA
Similar Awards
This $495,166 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports a research project at Fordham University titled "Molecular Mechanisms of Y-Family Translesion Polymerase Activity in Bacillus subtilis". The project aims to provide a comprehensive picture of the spatial organization, dynamics, and molecular coordination of the translesion DNA synthesis polymerases Pol Y1...
This Project Grant from the National Institutes of Health's National Institute of General Medical Sciences, under the Biomedical Research and Research Training program (CFDA 93.859), provides $754,986 to Baylor University from September 1, 2022 through August 31, 2025. The grant supports research into the mechanisms of DNA damage processing and initiation of nucleotide excision repair. Specifically, the grant will fund experiments using cryo-electron microscopy, time-resolved fluorescence...
This $700,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will support research at Baylor University to understand the structure and dynamics of enzyme catalysis. The goal is to combine structural biology and kinetics experiments to observe enzyme function in real-time and under different conditions, which can inform the design of new enzymes and inhibitor drugs. Specifically, the research...
Baylor University received a $1.1 million Project Grant award from the National Science Foundation under the Biological Sciences program (CFDA 47.074) for the period of March 1, 2022 through February 28, 2027. The award will support research into investigations of dynamic DNA recognition and processing during eukaryotic nucleotide excision repair. The research aims to obtain detailed molecular and structural understanding of critical steps in the initiation of nucleotide excision repair...
Baylor University will receive $805,201 over four years from the National Science Foundation under the Biological Sciences federal grant program (CFDA 47.074) to study the decoupling of DNA unwinding and synthesis in the replisome and induce genome instability. This Project Grant award, made on June 1, 2021, will fund research examining how the replication machinery unwinds and copies DNA, with the goal of increasing understanding of major biological problems as described in the program...
This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports two main research initiatives at Baylor University: Project 1 aims to expand the use of NMR-guided directed evolution techniques to create improved metalloenzyme catalysts for practical applications, such as pesticide/chemical weapons remediation, DNA hydrolysis, and phenol oxidation. The research will also help advance...
This Project Grant award from the National Science Foundation's Biological Sciences (CFDA 47.074) Federal Grant Program will provide $950,000 to Texas A&M University from June 1, 2025 to May 31, 2029. The project will investigate how the enzyme thymine DNA glycosylase, a key player in the DNA demethylation pathway, is targeted to specific methyl groups throughout the genome. This research aims to improve understanding of how DNA methylation landscapes are established and maintained under...
The National Institute of General Medical Sciences (NIGMS) awarded a $470,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Institute For Cancer Research, a non-profit subsidiary of Temple University, for a 5-year research project starting on September 17, 2024. The goal of the project is to characterize the molecular-level interactions and coordination events coupling the repair of oxidative DNA damage and gene enhancement at G-quadruplex promoter regions in...
This federal Project Grant award of $2,025,831 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports advanced research on the molecular mechanisms of eukaryotic chromosome replication. The grant aims to illuminate both the intrinsic functioning of the eukaryotic DNA replication machinery and its response to various replication stress conditions that can lead to genome instability and diseases like...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $390,000.00 in funding to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, for a project titled "Elucidating the Mechanisms Underlying DNA Double-Strand Break Repair". The project aims to investigate the molecular mechanisms and regulation of the DNA repair processes that address double-strand...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is providing $420,000 over 3 years (7/2/2024 - 6/30/2027) to Baylor University to characterize the molecular and structural mechanisms that regulate translesion DNA synthesis (TLS) in order to maintain genomic fidelity. The key objectives are to: 1) validate preliminary data showing that specific "kinetic trigger" residues in TLS DNA polymerases sense synthesis past lesions and promote polymerase dissociation, and 2) utilize full-length human DNA polymerase enzymes and accessory factors to further elucidate the substitution steps needed to bypass various DNA lesions while restricting low-fidelity synthesis. This research program will integrate advanced biochemical, enzymological, kinetic, and structural approaches to provide a clearer understanding of the TLS process and identify potential targets to prevent chemoresistance.

Generated 7/1/25, 2:30 AM